Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration.
D000452:Aldrin / Q000378:metabolism; D000818:Animals; D000840:Anisoles / Q000378:metabolism; D001571:Benzoflavones / Q000494:pharmacology; D002070:Butadienes / Q000494:pharmacology*; D003374:Coumarins / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System; D005260:Female; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000201:enzymology; D007850:Lauric Acids / Q000378:metabolism; D008297:Male; D051379:Mice; D010078:Oxazines / Q000378:metabolism; D010105:Oxygenases / Q000032:analysis* / Q000378:metabolism; D051381:Rats; D019324:beta-Naphthoflavone
D000840:Anisoles; D001571:Benzoflavones; D002070:Butadienes; D003374:Coumarins; D007850:Lauric Acids; D010078:Oxazines; C017299:7-ethoxycoumarin; C007649:ethoxyresorufin; D019324:beta-Naphthoflavone; D003577:Cytochrome P-450 Enzyme System; C001335:hexachlorobutadiene; D010105:Oxygenases; C005306:4-nitroanisole; D000452:Aldrin